RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19

NCT ID: NCT04397666

Last Updated: 2021-08-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

68 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-15

Study Completion Date

2021-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV Infection Pinkeye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

conjunctival RT PCR

Intervention Type DIAGNOSTIC_TEST

conjunctival sample in covid-19 patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

conjunctival RT PCR

conjunctival sample in covid-19 patients

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and Women positive for SARS-Cov-2 on a RT-PCR test of a sample of respiratory airway
* Persons over 18 years of age
* patients of both sexes
* Member of a social security scheme
* Having signed the consent form

Exclusion Criteria

* Minors not emancipated, persons out of state to express their consent
* Participation in intervention research on Covid-19 involving experimental treatment
* History of chronic disease conjunctiva
* Patient with one of the one of the criteria of following gravity:

1. EN \> or =30/min,
2. Pao2/Fio2 = or \< 300,
3. confusion and/or disorientation,
4. hypotension (Tas90mmhg, requiring aggressive filling),
5. need for a invasive ventilation,
6. septic shock
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Versailles Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Edouard KOCH

coordonator investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier de versailles

Le Chesnay, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P20/09_COVEYES

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.